Chromatan Corporation

Dedham, MA 02026

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.51MM
First Award Date 09/01/11
Most Recent Award Date 03/15/17

Key Personnel

Last Name Name Awards Contact
Shinkazh Oleg Shinkazh 6 Message

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/15/17 - 02/28/18

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 01/01/16 - 06/30/16

? DESCRIPTION (provided by applicant): The overall goal of the proposed SBIR project is to commercialize an Integrated Continuous and Single-use bio-production platform (ICS) for flexible and robust manufacturing of therapeutic proteins. This novel platform will enable continuous, single-use, and low cost purification of therapeutic proteins....

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/26/14 - 08/31/15

DESCRIPTION (provided by applicant): This SBIR Phase II revision proposal requests $175,000 of additional funding for the Chromatan Corporation to commercialize the Continuous Countercurrent Tangential Chromatography (CCTC) technology for the purification of high value biological products, e.g., monoclonal antibodies for the treatment of differe...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/14 - 08/31/15

DESCRIPTION: This SBIR Phase II proposal to NIH requests $985,000 funding for Chromatan, Inc. to scale up and commercialize Continuous Countercurrent Tangential Chromatography (CCTC) for the purification of high value biological products, e.g., monoclonal antibodies for the treatment of cancer and arthritis. Downstream processing currently acco...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/20/13 - 08/31/14

DESCRIPTION: This SBIR Phase II proposal to NIH requests $985,000 funding for Chromatan, Inc. to scale up and commercialize Continuous Countercurrent Tangential Chromatography (CCTC) for the purification of high value biological products, e.g., monoclonal antibodies for the treatment of cancer and arthritis. Downstream processing currently acco...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-113
Budget: 09/01/11 - 07/29/12

DESCRIPTION (provided by applicant): SBIR Phase I proposal to NIH requests $183,000 funding for Chromatan, Inc. to demonstrate the feasibility of using Continuous Countercurrent Tangential Chromatography (CCTC) for the purification of high value biological products, e.g., monoclonal antibodies for the treatment of cancer or recombinant vaccines ...